New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)
Main Authors: | Anna S. Berghoff, Angelika M. Starzer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | ESMO Open |
Online Access: | https://esmoopen.bmj.com/content/4/Suppl_3/e000629.full |
Similar Items
-
New emerging targets in cancer immunotherapy: the role of Cluster of Differentiation 40 (CD40/TNFR5)
by: Manuel Piechutta, et al.
Published: (2019-06-01) -
B7-H3/CD276: An Emerging Cancer Immunotherapy
by: Wu-Tong Zhou, et al.
Published: (2021-07-01) -
CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development
by: Kenji Hashimoto
Published: (2021-05-01) -
New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis
by: Ignacio Melero, et al.
Published: (2019-06-01) -
New emerging targets in cancer immunotherapy: the role of neoantigens
by: Leticia De Mattos-Arruda, et al.
Published: (2019-06-01)